After confirming the LXR‐loaded nanodiscs are able to increase expression of the ABCA1 cholesterol efflux transporter, we compared the effectiveness of each treatment with regards to cholesterol removal from glioma cells, as this is expected to be one of the main drivers of tumor cell death in vivo. This evidence concerns the gene ABCA1 and neoplasm.